Crede Blasts Tobacco Co. In $250M Suit Over China JV
22nd Century, a genetic engineering company specializing in low-nicotine tobacco, was hit with a $250 million contract suit in New York federal court Tuesday by its largest investor, private equity fund...To view the full article, register now.
Already a subscriber? Click here to view full article